Carlos Cano

Top-performing bilingual pharmaceutical professional with 20+ years of experience across Specialty Sales, Key Account Management, Market Access, and Sales Leadership. Deep expertise in pull-through initiatives, reimbursement strategy, buy-and-bill, infusion centers, and specialty pharmacies, driving access and sustainable growth. Proven leader in matrixed organizations, delivering consistent results recognized through awards and top-tier rankings in every role.

Fully bilingual in English and Spanish, with extensive experience across the U.S. mainland and Puerto Rico.

Key Account Manager – Gastroenterology - Takeda Pharmaceuticals USA - U.S. GI Specialty & Rare Disease | Florida & Puerto Rico

(2024-01)

Lead strategic contracting and executive-level engagement for major GI health systems, aligning customer initiatives with Takeda's corporate and brand objectives.

• Manage high‑value key accounts including Mayo Clinic, Cleveland Clinic, University of Miami, UF Health, AdventHealth, and Orlando Health.
• Drove Florida GI business to #1 in the Central Region, identifying growth opportunities and executing targeted, market-specific strategies across Florida and Puerto Rico.
• Provide actionable insights, structure compliance, value-based agreements, and ensure adherence to ethical and regulatory standards.
• Collaborate cross‑functionally (PAM, CES, MSL, Market Access) to deliver customized solutions that enhance access and strengthen partnerships.
• Currently ranked #1 and contending for Key Account Manager of the Year

Regional Business Manager – Hematology - Takeda Pharmaceuticals USA - South Florida & Puerto Rico

(2022-01 - 2024-01)

Drove sales growth for Takeda's hematology blood disorder portfolio through deep clinical dialogue with HCPs and staff across Hemophilia Treatment Centers and Hem‑Onc practices.

• Leveraged high clinical acumen in discussions across Hemophilia A, Von Willebrand Disease, and Congenital Thrombotic Thrombocytopenic Purpura.
• Worked in close partnership with CES, PAM, MSL, and KAM teams to deliver integrated customer strategies.
• Conducted business reviews with Hemophilia Alliance–contracted HTCs to optimize utilization and help customers maximize rebate value.
• Led engagement with specialty pharmacies and provider offices to support access, logistics, and continuity of care.
• IC Award Winner – 100%+ VONVENDI Goal Attainment (2022)
• IC Award Winner – 100%+ Achievement for VONVENDI & rFVIII (2023)
• Drove +985% growth for VONVENDI (2023)
• Expanded VONVENDI utilization outside HTCs for the first time since launch (2016)
• Achieved 48% rFVII share at University of Miami in a declining market
• Secured formulary inclusion for ADVATE and VONVENDI at major institutions

Clinical Sales Specialist – IBD - Takeda Pharmaceuticals USA - South Florida & Puerto Rico

(2018-01 - 2022-01)

Drove growth of vedolizumab (Entyvio) across South Florida and Puerto Rico by partnering with key gastroenterology practices and academic IBD centers.

• Managed strategic relationships with Gastro Health, Digestive Care, University of Miami, Cleveland Clinic, UPR School of Medicine IBD Center, and VA Caribbean Hospital.
• Global Values Ambassador – 2020
• Virtual Breakthrough Award – 2020
• District Business Lead – 2021
• Field Readiness Manager (FRM) Development Program – 2021

Clinical Sales Specialist - Takeda Pharmaceuticals USA - Florida East (Ft. Lauderdale – Orlando)

(2017-01 - 2018-01)

Turned around an underperforming territory, delivering 116% of goal in Orlando. Led pull‑through initiatives by identifying access barriers and educating offices on support programs and reimbursement pathways.

• Silver Cresset Award Winner (2017–2018)

Southeast Specialty Field Training Liaison - Takeda Pharmaceuticals USA

(2016-01 - 2017-01)

Initial Sales Training Class Advisor - Takeda Pharmaceuticals USA

(2016-01 - 2016-12)

Key Account Manager II / Business Relations (Access) Manager - Novartis Pharmaceuticals - Puerto Rico

(2012-01 - 2015-12)

Managed access strategy across cardiovascular, rheumatology, and Alzheimer's portfolios. Drove Reclast growth by identifying access barriers within infusion centers and improving specialty pharmacy collaboration. Educated leadership teams on root causes of denials and developed strategic remediation plans. Leveraged LTC pharmacy rebate contracting to increase product share.

• Ranked in Top 7% of region (2013–2014)
• Improved Reclast performance from 64% to 122% of goal

District Sales Manager - Novartis Pharmaceuticals - Puerto Rico

(2009-01 - 2012-12)

Led and developed a 13‑member sales team across hypertension, osteoporosis, and Alzheimer's. Fostered a diverse, inclusive culture with strong performance management and coaching.

• District Manager of the Year
• Global Sales Excellence Award (Ranked 2 of 105 DSMs nationally)
• Diversity & Inclusion Talent Pillar Co‑Chair

Senior Sales Consultant - Novartis Pharmaceuticals - Puerto Rico

(2000-01 - 2009-12)

Called on cardiology, nephrology, endocrinology, gastroenterology, and primary care across metro San Juan. Built strong partnerships with hospitals, managed care organizations, and the Puerto Rico Gastroenterology Association (APG).

• Two‑time District of the Year Award
• Tekturna Launch Drive Award
• Top 15% performer nationally
• Top Pod Award – Highest performing team

MBA - Accounting - Interamerican University of Puerto Rico

BBA - Marketing - University of Puerto Rico